Skip to main content

Find Clinical Trials

Home
Conditions
Minimal Residual Disease

Clinical trial condition

Minimal Residual Disease

Explore clinical trials studying Minimal Residual Disease. Study availability and eligibility vary by location and protocol.

48 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Minimal Residual Disease trial results

Not Yet Recruiting

Monitoring MRD in Multiple Myeloma in Serum by Mass Spectrometry

NCT07691034

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Integrating Allogeneic NK Cells in High-risk Advanced Stage III-IV Nasopharyngeal Cancer Patients

NCT07247201

Conditions: Carcinoma, Head and Neck Neoplasms, Maximum Tolerated Dose, +19 more
Locations: Singapore General Hospital Singapore

View Trial Details

Not Yet Recruiting

Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial

NCT07413146

Conditions: Colon Cancer (Stage II &Amp; III), Colonic Diseases, Colonic Neoplasms, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC

NCT07350824

Conditions: Disease Attributes, HCC, Minimal Residual Disease, +6 more
Locations: Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer

NCT06941987

Conditions: Minimal Residual Disease, Neoplasm, Residual, Neoplasms, +4 more
Locations: Zhongshan Hospital, Shanghai Shanghai, China

View Trial Details

Not Yet Recruiting

NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL

NCT06763302

Conditions: B Cell Precursor Acute Lymphoblastic Leukemia, Minimal Residual Disease, Neoplasm, Residual, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Kinetics and Impact on Survival of MRD in AML Patients Receiving Azacitidine and Venetoclax

NCT06090786

Conditions: AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)

NCT06323148

Conditions: EGFR Gene Mutation, Lung Cancer, Lung Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia

NCT05987696

Conditions: AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Completed

A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)

NCT05429320

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations: Hartford Healthcare ALLIANCE (Data collection only) Hartford, Connecticut, United States

BAPTIST ALLIANCE - MCI (Data collection only) Miami, Florida, United States

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

View Trial Details